4.7 Letter

Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cultured Vero cells

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Stilbene-based natural compounds as promising drug candidates against COVID-19

Hussain Mustatab Wahedi et al.

Summary: The study suggests that stilbenoid compounds, especially resveratrol, could be promising candidates for anti-COVID-19 drugs by disrupting the structure of the viral protein.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Medicine, General & Internal

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

B. Cao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Resveratrol affects Zika virus replication in vitro

Azirah Mohd et al.

SCIENTIFIC REPORTS (2019)

Article Infectious Diseases

Effective inhibition of MERS-CoV infection by resveratrol

Shih-Chao Lin et al.

BMC INFECTIOUS DISEASES (2017)

Article Agriculture, Dairy & Animal Science

Resveratrol compares with melatonin in improving in vitro porcine oocyte maturation under heat stress

Yu Li et al.

JOURNAL OF ANIMAL SCIENCE AND BIOTECHNOLOGY (2016)

Article Biochemistry & Molecular Biology

Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network

Clemence D. Cote et al.

NATURE MEDICINE (2015)